Journals / Infectious diseases and clinical microbiology (Online) / 2021 / Cilt: 3 - Sayı: 3

Comparison of Crystal Violet Staining Assay and XTT Methods in the Evaluation of Biofilm Formation in Candida parapsilosis Candidemia Isolates

Pages
158–163
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to these results, when evaluating the biofilm levels of C. parapsilosis isolates, high OD values obtained by the XTT method should be confirmed with the CV method.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Biofilm formation is one of the most important virulence factors of Candida species which leads to permanent infection foci by adhering to foreign materials and which are difficult to treat.
📊
Key Findings & Data:The most commonly used methods for evaluating the biofilm formation of Candida species are measuring cell viability with XTT (2,3-bis (2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide) and evaluating the total biofilm mass with crystal violet (CV).
💡
Conclusion & Impact:According to these results, when evaluating the biofilm levels of C. parapsilosis isolates, high OD values obtained by the XTT method should be confirmed with the CV method.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Biofilm formation is one of the most important virulence factors of Candida species which leads to permanent infection foci by adhering to foreign materials and which are difficult to treat. Candida parapsilosis, which is one of the most common causes of candidemia in our country, is frequently isolated as a causative agent in catheterrelated infections. The most commonly used methods for evaluating the biofilm formation of Candida species are measuring cell viability with XTT (2,3-bis (2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide) and evaluating the total biofilm mass with crystal violet (CV). The aim of this study is to evaluate the biofilm formation ability of C. parapsilosis candidemia isolates by XTT and (CV) methods and compare these methods with each other. Materials and Methods: C. parapsilosis isolates sent from various hospitals between 2015 and 2019 were included in the study retrospectively, and the species-level identification was performed using the matrix- assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) The biofilm formation of the isolates was compared based on the optical density (OD) values obtained by crystal violet and XTT methods. The biofilm formation of the isolates was evaluated by categorizing them into low, medium and high biofilm groups as ± 20% according to the median value of all strains. Results: Totally, 79 C. parapsilosis candidemia isolates were included in this study and categorical compatibility between CV and XTT methods in low, medium and high biofilm groups was found as 69.6%, 60.6% and 73.9%, respectively. The OD values of the XTT method in the high biofilm group were found statistically significantly higher when compared with the values from the CV method. Conclusion: The compatibility of XTT and crystal violet methods in terms of biofilm measurement in C. parapsilosis isolates was considered acceptable, and no major variations were detected between the categories. According to these results, when evaluating the biofilm levels of C. parapsilosis isolates, high OD values obtained by the XTT method should be confirmed with the CV method.

🔖

Cite This Article

DOĞAN, Ö., CAN, F., ATAÇ, N., BABUCCU, G. (2022). Comparison of Crystal Violet Staining Assay and XTT Methods in the Evaluation of Biofilm Formation in Candida parapsilosis Candidemia Isolates. Infectious diseases and clinical microbiology (Online), Cilt: 3 - Sayı: 3, 158–163. https://ajindex.com/articles/539070

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. 1 Potera C. Forging a link between biofilms and disease. Science. 1999
  2. 283(5409):1837-9. [CrossRef] 2 Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis. 2001
  3. 33(8):1387-92. [CrossRef] 3 Eix EF, Nett JE. How biofilm growth affects Candida-host interactions. Front Microbiol. 2020
  4. [CrossRef] 4 Mah TF, O’Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001
  5. 9(1):34-9. [CrossRef] 5 Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 2003
  6. 11(1):30-6. [CrossRef] 6 Cavalheiro M, Teixeira MC. Candida biofilms: Threats, challenges, and promising strategies. Front Med (Lausanne). 2018
  7. [CrossRef] 7 Antinori S, Milazzo L, Sollima S, Galli M, Corbellino M. Candidemia and invasive candidiasis in adults: A narrative review. Eur J Intern Med. 2016
  8. [CrossRef] 8 Ramage G, Martínez JP, López-Ribot JL. Candida biofilms on implanted biomaterials: A clinically significant problem. FEMS Yeast Res. 2006
  9. 6(7):979-86. [CrossRef] 9 Hu B, Du Z, Kang Y, Zang B, Cui W, Qin B, et al. Catheter-related Candida bloodstream infection in intensive care unit patients: A subgroup analysis of the China-SCAN study. BMC Infect Dis. 2014
  10. [CrossRef] 10 Arikan-Akdagli S, Gülmez D, Doğan Ö, Çerikçioğlu N, Doluca Dereli M, Birinci A, et al. First multicentre report of in vitro resistance rates in candidaemia isolates in Turkey. J Glob Antimicrob Resist. 2019
  11. [CrossRef] 11 Tóth R, Nosek J, Mora-Montes HM, Gabaldon T, Bliss JM, Nosanchuk JD, et al. Candida parapsilosis: From genes to the bedside. Clin Microbiol Rev. 2019
  12. 32(2):e00111-18. [CrossRef] 12 Kuhn DM, Balkis M, Chandra J, Mukherjee PK, Ghannoum MA. Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J Clin Microbiol. 2003
  13. 41(1):506-8. [CrossRef] 13 Melo AS, Bizerra FC, Freymüller E, Arthington-Skaggs BA, Colombo AL. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med Mycol. 2011
  14. 49(3):253-62. [CrossRef] 14 Bouza E, Guinea J, Guembe M. The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia. Antibiotics (Basel). 2014
  15. 4(1):1-17. [CrossRef] 15 Monfredini PM, Souza ACR, Cavalheiro RP, Siqueira RA, Colombo AL. Clinical impact of Candida spp. biofilm production in a cohort of patients with candidemia. Med Mycol. 2018
  16. 56(7):803- 8. [CrossRef] 16 Tu